Literature DB >> 29771685

Enterotoxigenic Escherichia coli-blood group A interactions intensify diarrheal severity.

Pardeep Kumar1, F Matthew Kuhlmann1, Subhra Chakraborty2, A Louis Bourgeois2, Jennifer Foulke-Abel3, Brunda Tumala1, Tim J Vickers1, David A Sack2, Barbara DeNearing2, Clayton D Harro2, W Shea Wright4, Jeffrey C Gildersleeve4, Matthew A Ciorba5, Srikanth Santhanam5, Chad K Porter6, Ramiro L Gutierrez6, Michael G Prouty6, Mark S Riddle6, Alexander Polino7, Alaullah Sheikh7, Mark Donowitz3, James M Fleckenstein1,7,8.   

Abstract

Enterotoxigenic Escherichia coli (ETEC) infections are highly prevalent in developing countries, where clinical presentations range from asymptomatic colonization to severe cholera-like illness. The molecular basis for these varied presentations, which may involve strain-specific virulence features as well as host factors, has not been elucidated. We demonstrate that, when challenged with ETEC strain H10407, originally isolated from a case of cholera-like illness, blood group A human volunteers developed severe diarrhea more frequently than individuals from other blood groups. Interestingly, a diverse population of ETEC strains, including H10407, secrete the EtpA adhesin molecule. As many bacterial adhesins also agglutinate red blood cells, we combined the use of glycan arrays, biolayer inferometry, and noncanonical amino acid labeling with hemagglutination studies to demonstrate that EtpA is a dominant ETEC blood group A-specific lectin/hemagglutinin. Importantly, we have also shown that EtpA interacts specifically with glycans expressed on intestinal epithelial cells from blood group A individuals and that EtpA-mediated bacterial-host interactions accelerate bacterial adhesion and effective delivery of both the heat-labile and heat-stable toxins of ETEC. Collectively, these data provide additional insight into the complex molecular basis of severe ETEC diarrheal illness that may inform rational design of vaccines to protect those at highest risk.

Entities:  

Keywords:  Bacterial infections; Bacterial vaccines; Glycobiology; Infectious disease; Vaccines

Mesh:

Substances:

Year:  2018        PMID: 29771685      PMCID: PMC6063478          DOI: 10.1172/JCI97659

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  88 in total

1.  Enterotoxigenic Escherichia coli isolated from patients with severe cholera-like disease.

Authors:  R B Sack; S L Gorbach; J G Banwell; B Jacobs; B D Chatterjee; R C Mitra
Journal:  J Infect Dis       Date:  1971-04       Impact factor: 5.226

Review 2.  Human enteroids as an ex-vivo model of host-pathogen interactions in the gastrointestinal tract.

Authors:  Jennifer Foulke-Abel; Julie In; Olga Kovbasnjuk; Nicholas C Zachos; Khalil Ettayebi; Sarah E Blutt; Joseph M Hyser; Xi-Lei Zeng; Sue E Crawford; James R Broughman; Mary K Estes; Mark Donowitz
Journal:  Exp Biol Med (Maywood)       Date:  2014-04-09

3.  Functional adaptation of BabA, the H. pylori ABO blood group antigen binding adhesin.

Authors:  Marina Aspholm-Hurtig; Giedrius Dailide; Martina Lahmann; Awdhesh Kalia; Dag Ilver; Niamh Roche; Susanne Vikström; Rolf Sjöström; Sara Lindén; Anna Bäckström; Carina Lundberg; Anna Arnqvist; Jafar Mahdavi; Ulf J Nilsson; Billie Velapatiño; Robert H Gilman; Markus Gerhard; Teresa Alarcon; Manuel López-Brea; Teruko Nakazawa; James G Fox; Pelayo Correa; Maria Gloria Dominguez-Bello; Guillermo I Perez-Perez; Martin J Blaser; Staffan Normark; Ingemar Carlstedt; Stefan Oscarson; Susann Teneberg; Douglas E Berg; Thomas Borén
Journal:  Science       Date:  2004-07-23       Impact factor: 47.728

4.  Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli.

Authors:  C O Tacket; G Losonsky; H Link; Y Hoang; P Guesry; H Hilpert; M M Levine
Journal:  N Engl J Med       Date:  1988-05-12       Impact factor: 91.245

5.  Structural Insights into Polymorphic ABO Glycan Binding by Helicobacter pylori.

Authors:  Kristof Moonens; Pär Gideonsson; Suresh Subedi; Jeanna Bugaytsova; Ema Romaõ; Melissa Mendez; Jenny Nordén; Mahsa Fallah; Lena Rakhimova; Anna Shevtsova; Martina Lahmann; Gaetano Castaldo; Kristoffer Brännström; Fanny Coppens; Alvin W Lo; Tor Ny; Jay V Solnick; Guy Vandenbussche; Stefan Oscarson; Lennart Hammarström; Anna Arnqvist; Douglas E Berg; Serge Muyldermans; Thomas Borén; Han Remaut
Journal:  Cell Host Microbe       Date:  2016-01-13       Impact factor: 21.023

6.  Evidence of regio-specific glycosylation in human intestinal mucins: presence of an acidic gradient along the intestinal tract.

Authors:  Catherine Robbe; Calliope Capon; Emmanuel Maes; Monique Rousset; Alain Zweibaum; Jean-Pierre Zanetta; Jean-Claude Michalski
Journal:  J Biol Chem       Date:  2003-09-02       Impact factor: 5.157

7.  An outbreak of enterotoxigenic Escherichia coli associated with sushi restaurants in Nevada, 2004.

Authors:  Seema Jain; Lei Chen; Amy Dechet; Alan T Hertz; Debra L Brus; Kathleen Hanley; Brenda Wilson; Jaime Frank; Kathy D Greene; Michele Parsons; Cheryl A Bopp; Randall Todd; Michael Hoekstra; Eric D Mintz; Pavani K Ram
Journal:  Clin Infect Dis       Date:  2008-07-01       Impact factor: 9.079

8.  Disease burden due to enterotoxigenic Escherichia coli in the first 2 years of life in an urban community in Bangladesh.

Authors:  Firdausi Qadri; Amit Saha; Tanvir Ahmed; Abdullah Al Tarique; Yasmin Ara Begum; Ann-Mari Svennerholm
Journal:  Infect Immun       Date:  2007-06-04       Impact factor: 3.441

9.  Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study.

Authors:  Jie Liu; James A Platts-Mills; Jane Juma; Furqan Kabir; Joseph Nkeze; Catherine Okoi; Darwin J Operario; Jashim Uddin; Shahnawaz Ahmed; Pedro L Alonso; Martin Antonio; Stephen M Becker; William C Blackwelder; Robert F Breiman; Abu S G Faruque; Barry Fields; Jean Gratz; Rashidul Haque; Anowar Hossain; M Jahangir Hossain; Sheikh Jarju; Farah Qamar; Najeeha Talat Iqbal; Brenda Kwambana; Inacio Mandomando; Timothy L McMurry; Caroline Ochieng; John B Ochieng; Melvin Ochieng; Clayton Onyango; Sandra Panchalingam; Adil Kalam; Fatima Aziz; Shahida Qureshi; Thandavarayan Ramamurthy; James H Roberts; Debasish Saha; Samba O Sow; Suzanne E Stroup; Dipika Sur; Boubou Tamboura; Mami Taniuchi; Sharon M Tennant; Deanna Toema; Yukun Wu; Anita Zaidi; James P Nataro; Karen L Kotloff; Myron M Levine; Eric R Houpt
Journal:  Lancet       Date:  2016-09-24       Impact factor: 79.321

10.  Immunogenicity and Protective Efficacy against Enterotoxigenic Escherichia coli Colonization following Intradermal, Sublingual, or Oral Vaccination with EtpA Adhesin.

Authors:  Qingwei Luo; Tim J Vickers; James M Fleckenstein
Journal:  Clin Vaccine Immunol       Date:  2016-07-05
View more
  28 in total

Review 1.  Enterotoxigenic Escherichia coli Infections.

Authors:  James M Fleckenstein; F Matthew Kuhlmann
Journal:  Curr Infect Dis Rep       Date:  2019-03-04       Impact factor: 3.725

2.  CEACAMs serve as toxin-stimulated receptors for enterotoxigenic Escherichia coli.

Authors:  Alaullah Sheikh; Brunda Tumala; Tim J Vickers; David Alvarado; Matthew A Ciorba; Taufiqur Rahman Bhuiyan; Firdausi Qadri; Bernhard B Singer; James M Fleckenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-02       Impact factor: 11.205

3.  Molecular Determinants of Enterotoxigenic Escherichia coli Heat-Stable Toxin Secretion and Delivery.

Authors:  Yuehui Zhu; Qingwei Luo; Sierra M Davis; Chase Westra; Tim J Vickers; James M Fleckenstein
Journal:  Infect Immun       Date:  2018-10-25       Impact factor: 3.441

Review 4.  Controlling the polarity of human gastrointestinal organoids to investigate epithelial biology and infectious diseases.

Authors:  Julia Y Co; Mar Margalef-Català; Denise M Monack; Manuel R Amieva
Journal:  Nat Protoc       Date:  2021-10-18       Impact factor: 13.491

5.  Histo-blood group antigens of glycosphingolipids predict susceptibility of human intestinal enteroids to norovirus infection.

Authors:  Inga Rimkute; Konrad Thorsteinsson; Marcus Henricsson; Victoria R Tenge; Xiaoming Yu; Shih-Ching Lin; Kei Haga; Robert L Atmar; Nils Lycke; Jonas Nilsson; Mary K Estes; Marta Bally; Göran Larson
Journal:  J Biol Chem       Date:  2020-09-10       Impact factor: 5.157

Review 6.  Acute Bacterial Gastroenteritis.

Authors:  James M Fleckenstein; F Matthew Kuhlmann; Alaullah Sheikh
Journal:  Gastroenterol Clin North Am       Date:  2021-04-23       Impact factor: 3.806

7.  Contribution of Noncanonical Antigens to Virulence and Adaptive Immunity in Human Infection with Enterotoxigenic E. coli.

Authors:  F M Kuhlmann; R O Laine; S Afrin; R Nakajima; M Akhtar; T Vickers; K Parker; N N Nizam; V Grigura; C W Goss; P L Felgner; D A Rasko; F Qadri; J M Fleckenstein
Journal:  Infect Immun       Date:  2021-04-16       Impact factor: 3.441

Review 8.  Enterotoxigenic Escherichia coli (ETEC) vaccines: Priority activities to enable product development, licensure, and global access.

Authors:  Ibrahim Khalil; Richard Walker; Chad K Porter; Farzana Muhib; Roma Chilengi; Alejandro Cravioto; Richard Guerrant; Ann-Mari Svennerholm; Firdausi Qadri; Shahida Baqar; Margaret Kosek; Gagandeep Kang; Claudio Lanata; George Armah; Thomas Wierzba; Mateusz Hasso-Agopsowicz; Birgitte Giersing; A Louis Bourgeois
Journal:  Vaccine       Date:  2021-05-06       Impact factor: 3.641

9.  The Intriguing Interaction of Escherichia coli with the Host Environment and Innovative Strategies To Interfere with Colonization: a Summary of the 2019 E. coli and the Mucosal Immune System Meeting.

Authors:  Eric Cox; Meryem Aloulou; James M Fleckenstein; Christina Schäffer; Åsa Sjöling; Stephanie Schüller; Kurt Hanevik; Bert Devriendt; Weiping Zhang; Ann-Mari Svennerholm; Edward G Dudley
Journal:  Appl Environ Microbiol       Date:  2020-11-24       Impact factor: 4.792

Review 10.  Glycan-mediated molecular interactions in bacterial pathogenesis.

Authors:  Sohyoung Lee; Sean Inzerillo; Gi Young Lee; Erick M Bosire; Saroj K Mahato; Jeongmin Song
Journal:  Trends Microbiol       Date:  2021-07-14       Impact factor: 17.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.